104 related articles for article (PubMed ID: 20976000)
1. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
[TBL] [Abstract][Full Text] [Related]
2. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.
Mane A; Nirmalkar A; Risbud AR; Vermund SH; Mehendale SM; Sahasrabuddhe VV
PLoS One; 2012; 7(6):e38731. PubMed ID: 22723879
[TBL] [Abstract][Full Text] [Related]
3. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.
Singh DK; Anastos K; Hoover DR; Burk RD; Shi Q; Ngendahayo L; Mutimura E; Cajigas A; Bigirimani V; Cai X; Rwamwejo J; Vuolo M; Cohen M; Castle PE
J Infect Dis; 2009 Jun; 199(12):1851-61. PubMed ID: 19435429
[TBL] [Abstract][Full Text] [Related]
5. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women.
Heard I; Etienney I; Potard V; Poizot-Martin I; Moore C; Lesage AC; Ressiot E; Crenn-Hebert C; Fléjou JF; Cubie H; Costagliola D; Darragh TM;
Clin Infect Dis; 2015 May; 60(10):1559-68. PubMed ID: 25645213
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
11. Incidence of cervical precancers among HIV-seropositive women.
Massad LS; Xie X; D'Souza G; Darragh TM; Minkoff H; Wright R; Colie C; Sanchez-Keeland L; Strickler HD
Am J Obstet Gynecol; 2015 May; 212(5):606.e1-8. PubMed ID: 25499260
[TBL] [Abstract][Full Text] [Related]
12. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
Zhang HY; Fei MD; Jiang Y; Fei QY; Qian H; Xu L; Jin YN; Jiang CQ; Li HX; Tiggelaar SM; Smith JS; Sahasrabuddhe VV; Qiao YL
Virol J; 2014 Dec; 11():202. PubMed ID: 25481842
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
Castle PE; Dockter J; Giachetti C; Garcia FA; McCormick MK; Mitchell AL; Holladay EB; Kolk DP
Clin Cancer Res; 2007 May; 13(9):2599-605. PubMed ID: 17473189
[TBL] [Abstract][Full Text] [Related]
14. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study.
Gedefaw A; Astatkie A; Tessema GA
PLoS One; 2013; 8(12):e84519. PubMed ID: 24376818
[TBL] [Abstract][Full Text] [Related]
16. Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.
Mukanyangezi MF; Rugwizangoga B; Manzi O; Rulisa S; Hellstrand K; Tobin G; Martner A; Bienvenu E; Giglio D
HIV Med; 2019 Aug; 20(7):485-495. PubMed ID: 31318136
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
Castilho JL; Levi JE; Luz PM; Cambou MC; Vanni T; de Andrade A; Derrico M; Veloso VG; Grinsztejn B; Friedman RK
BMC Cancer; 2015 Jun; 15():478. PubMed ID: 26100400
[TBL] [Abstract][Full Text] [Related]
18. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
19. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study.
Kassa LS; Dile WM; Zenebe GK; Berta AM
Afr Health Sci; 2019 Mar; 19(1):1695-1704. PubMed ID: 31149000
[TBL] [Abstract][Full Text] [Related]
20. Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women.
Gradissimo A; Lam J; Attonito JD; Palefsky J; Massad LS; Xie X; Eltoum IE; Rahangdale L; Fischl MA; Anastos K; Minkoff H; Xue X; D'Souza G; Flowers LC; Colie C; Shrestha S; Hessol NA; Strickler HD; Burk RD
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1407-1415. PubMed ID: 30237251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
